{"version":"1.0","type":"link","title":"Targeting CRTC2 reverses  mutant NSCLC tumor resistance to immunotherapy.","author_name":"Robay D 외","author_url":"https://prs-insight.online/author/Robay%20D","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/93765","thumbnail_width":1200,"thumbnail_height":630}